🕷️ Crawler Inspector

URL Lookup

Direct Parameter Lookup

Raw Queries and Responses

1. Shard Calculation

Query:
Response:
Calculated Shard: 84 (from laksa023)

2. Crawled Status Check

Query:
Response:

3. Robots.txt Check

Query:
Response:

4. Spam/Ban Check

Query:
Response:

5. Seen Status Check

ℹ️ Skipped - page is already crawled

📄
INDEXABLE
✅
CRAWLED
2 months ago
🤖
ROBOTS ALLOWED

Page Info Filters

FilterStatusConditionDetails
HTTP statusPASSdownload_http_code = 200HTTP 200
Age cutoffPASSdownload_stamp > now() - 6 MONTH2.1 months ago
History dropPASSisNull(history_drop_reason)No drop reason
Spam/banPASSfh_dont_index != 1 AND ml_spam_score = 0ml_spam_score=0
CanonicalPASSmeta_canonical IS NULL OR = '' OR = src_unparsedNot set

Page Details

PropertyValue
URLhttps://www.nytimes.com/2022/03/23/health/sinovac-coronavirus-booster-hong-kong.html
Last Crawled2026-02-10 03:15:54 (2 months ago)
First Indexed2022-03-23 22:54:30 (4 years ago)
HTTP Status Code200
Meta TitleSinovac Booster Gives Elderly Stronger Protection Against Omicron, Study Finds - The New York Times
Meta DescriptionGiven the surge of Omicron cases in Asia, the new research lends urgency to vaccination campaigns in China and Hong Kong.
Meta Canonicalnull
Boilerpipe Text
Advertisement SKIP ADVERTISEMENT Given the surge of Omicron cases in Asia, the new research lends urgency to vaccination campaigns in China and Hong Kong. Masks were distributed to people leaving a Sinovac vaccination site in Hong Kong this month. Credit... Dale De La Rey/Agence France-Presse — Getty Images March 23, 2022 Two doses of China’s Sinovac vaccine offered older people only a moderately high level of protection against severe disease and death from Covid-19, but a third dose significantly bolstered their defenses, according to a new study by scientists in Hong Kong . The study, based on patients infected during the current devastating Omicron wave in Hong Kong , serves as a cautionary note for mainland China, where Sinovac is a pillar of the country’s vaccination program. Many older people there have yet to receive booster shots. For people 60 and older, two Sinovac doses were 72 percent effective against severe or fatal Covid-19 and 77 percent effective against Covid-related death, the study found. Those levels of protection were lower than those provided by two Pfizer-BioNTech doses. The same study found they were 90 percent effective against severe or fatal Covid and 92 percent effective against death among Hong Kong residents of the same age group. A Sinovac booster shot helped considerably, proving to be 98 percent effective against severe or fatal Covid among people at least 60 years old, the study found. Yanzhong Huang, a global health expert at the Council on Foreign Relations, said that the results highlighted the urgency for mainland China to accelerate its lagging booster campaign. “There’s a lot of work for the government to do to make sure this segment of the population receives the booster shots,” he said. The study’s authors, who are scientists at the University of Hong Kong, noted that the city’s booster program began just recently, making it difficult to determine how long protection from a third dose would last. Because people with underlying health conditions in Hong Kong were more likely to resist getting vaccinated, they said, it was also possible that those who chose to be vaccinated or boosted were healthier in the first place, inflating estimates of how protective the vaccines initially were. Sinovac, a private Chinese company that makes the vaccine, is one of two manufacturers of Covid shots available in China. Vaccines using mRNA technology, like those made by Pfizer-BioNTech and Moderna, are not available there. The new study highlights the potential consequences for China, which has relied heavily on Sinovac and is battling its biggest Covid outbreak in two years. More than 87 percent of China’s population has been vaccinated. But just over half of people 80 and older have had two shots, and less than 20 percent of people in that age group have received a booster, Zeng Yixin, a vice minister of the National Health Commission, said recently. The new study from Hong Kong received funding from the Chinese Center for Disease Control and Prevention as part of what one of the study’s co-authors described this week as an effort to understand the comparative effectiveness of vaccines. It was posted online as a preprint, but has not yet been vetted by peer scientists for publication in a scientific journal. Sinovac’s vaccine performed similarly to Pfizer’s among younger people, even without a booster dose, the study found. In people younger than 60, two Sinovac doses were roughly 92 percent effective against severe or fatal Covid, whereas two Pfizer doses were about 95 percent effective. Neither vaccine provided very much protection against mild or moderate Covid, though Pfizer’s offered more than Sinovac’s and a booster dose considerably lifted levels of protection. During the latest wave, people in Hong Kong have largely been infected by the subvariant of Omicron known as BA.2. Like other versions of Omicron, BA.2 has infected many vaccinated people. The Hong Kong wave is killing people at a rate exceeding that of almost any country since the coronavirus emerged — a result, in large part, of low vaccination rates among older residents. Almost 90 percent of people who died during the latest wave were not fully immunized, suggesting that getting shots to the most vulnerable is more important than the particular brand of vaccine. Like Hong Kong, mainland China had largely succeeded in tamping down transmission of the virus before Omicron, leaving its population with very little immunity from previous infections. Beyond China, Sinovac vaccines have also been critical in protecting people against severe Covid, especially in poorer countries. The vaccine is being used in 49 countries, including in South America and Africa. But concerns about the protection it offered had already prompted the World Health Organization to recommend in October that recipients 60 and older get a third dose. Dr. Andrew Morris, an infectious disease specialist at Sinai Health and University Health Network in Toronto, who was not involved with the Hong Kong study, said that the results fit with lab studies suggesting that Sinovac generated lower levels of neutralizing antibodies than mRNA vaccines, like Pfizer’s. “I think what we’ll see is in countries that have relied heavily on Sinovac, if they don’t have boosting — especially with an mRNA booster, or even with Sinovac — they’re probably going to struggle with high rates of infection with this latest BA.2 wave,” he said. Dr. Morris said that the results in Hong Kong, like those from other vaccine studies, were also highly dependent on how long it had been since people were administered the shots. Protection tends to weaken over time. The results from the latest study about the effectiveness of third Sinovac doses might be taken as an encouraging sign by Chinese leaders that Chinese-made vaccines could remain the focus of their immunization campaign, said Dr. Huang, of the Council on Foreign Relations. “Now, for the Chinese leaders, they don’t need to face a strong pressure to approve BioNTech’s vaccine,” he said. Benjamin Mueller is a health and science reporter. Previously, he covered the coronavirus pandemic as a correspondent in London and the police in New York. A version of this article appears in print on March 24, 2022 , Section A, Page 6 of the New York edition with the headline: Study of Chinese Vaccine Finds Booster Significantly Adds to Protection . Order Reprints | Today’s Paper | Subscribe Related Content The Covid-19 Pandemic Gabriela Bhaskar for The New York Times Alyssa Pointer/Reuters Tara Weston for The New York Times More in Health Alamy California Department of Public Health, via Associated Press Evelyn Hockstein/Reuters Scott Olson/Getty Images Editors’ Picks NBC Trending in The Times U.S. Atomic Energy Commission, via Associated Press Photo Illustration by The New York Times; Photo: Loren Elliott for The New York Times Image by Ghazalle Badiozamani for The New York Times Image by Alexandre Louvenaz Image by James Hill for The New York Times Lora Reynolds Natasha Campos/Getty Images For Mark Markiplier Alain Hamel Advertisement SKIP ADVERTISEMENT
Markdown
[Skip to content](https://www.nytimes.com/2022/03/23/health/sinovac-coronavirus-booster-hong-kong.html#site-content)[Skip to site index](https://www.nytimes.com/2022/03/23/health/sinovac-coronavirus-booster-hong-kong.html#site-index) Search & Section Navigation Section Navigation Search [Health](https://www.nytimes.com/section/health) [Log in](https://myaccount.nytimes.com/auth/login?response_type=cookie&client_id=vi&redirect_uri=https%3A%2F%2Fwww.nytimes.com%2Fsubscription%2Fonboarding-offer%3FcampaignId%3D7JFJX%26EXIT_URI%3Dhttps%253A%252F%252Fwww.nytimes.com%252F2022%252F03%252F23%252Fhealth%252Fsinovac-coronavirus-booster-hong-kong.html&asset=masthead) Monday, February 9, 2026 [Today’s Paper](https://www.nytimes.com/section/todayspaper) U.S. Health Policy - [Covid Shots](https://www.nytimes.com/2026/02/06/health/vaccines-covid-acip-malone-kennedy.html) - [‘Naturally Derived’ Dyes](https://www.nytimes.com/2026/02/05/us/politics/kennedy-fda-food-dyes-protein.html) - [Federal Autism Panel](https://www.nytimes.com/2026/01/29/health/autism-panel-kennedy-iacc.html) - [Approach to Immunization](https://www.nytimes.com/2026/01/11/health/kennedy-vaccines-children.html) - [Vaccine Changes](https://www.nytimes.com/2026/01/06/well/cdc-vaccine-schedule-recommendations.html) Advertisement [SKIP ADVERTISEMENT](https://www.nytimes.com/2022/03/23/health/sinovac-coronavirus-booster-hong-kong.html#after-top) Supported by [SKIP ADVERTISEMENT](https://www.nytimes.com/2022/03/23/health/sinovac-coronavirus-booster-hong-kong.html#after-sponsor) # Sinovac Boosters Provide Key Protection for Older People, New Study Finds Given the surge of Omicron cases in Asia, the new research lends urgency to vaccination campaigns in China and Hong Kong. - Share full article ![](https://static01.nyt.com/images/2022/03/23/science/23VIRUS-SINOVAC/merlin_203634372_62932c1b-ed9b-4ba6-8f77-b7db8021bbd8-articleLarge.jpg?quality=75&auto=webp&disable=upscale) Masks were distributed to people leaving a Sinovac vaccination site in Hong Kong this month.Credit...Dale De La Rey/Agence France-Presse — Getty Images [![Benjamin Mueller](https://static01.nyt.com/images/2018/02/20/multimedia/author-benjamin-mueller/author-benjamin-mueller-thumbLarge-v2.png)](https://www.nytimes.com/by/benjamin-mueller) By [Benjamin Mueller](https://www.nytimes.com/by/benjamin-mueller) March 23, 2022 [阅读简体中文版](https://cn.nytimes.com/health/20220324/sinovac-coronavirus-booster-hong-kong/ "Read in Simplified Chinese")[閱讀繁體中文版](https://cn.nytimes.com/health/20220324/sinovac-coronavirus-booster-hong-kong/zh-hant/ "Read in Traditional Chinese") Two doses of China’s Sinovac vaccine offered older people only a moderately high level of protection against severe disease and death from Covid-19, but a third dose significantly bolstered their defenses, according to a [new study by scientists in Hong Kong](https://www.medrxiv.org/content/10.1101/2022.03.22.22272769v1). The study, based on patients infected during the current devastating [Omicron wave in Hong Kong](https://www.nytimes.com/2022/03/21/health/covid-hong-kong-deaths.html), serves as a cautionary note for mainland China, where Sinovac is a pillar of the country’s vaccination program. Many older people there have yet to receive booster shots. For people 60 and older, two Sinovac doses were 72 percent effective against severe or fatal Covid-19 and 77 percent effective against Covid-related death, the study found. Those levels of protection were lower than those provided by two Pfizer-BioNTech doses. The same study found they were 90 percent effective against severe or fatal Covid and 92 percent effective against death among Hong Kong residents of the same age group. A Sinovac booster shot helped considerably, proving to be 98 percent effective against severe or fatal Covid among people at least 60 years old, the study found. Yanzhong Huang, a global health expert at the Council on Foreign Relations, said that the results highlighted the urgency for mainland China to accelerate its lagging booster campaign. “There’s a lot of work for the government to do to make sure this segment of the population receives the booster shots,” he said. The study’s authors, who are scientists at the University of Hong Kong, noted that the city’s booster program began just recently, making it difficult to determine how long protection from a third dose would last. Because people with underlying health conditions in Hong Kong were more likely to resist getting vaccinated, they said, it was also possible that those who chose to be vaccinated or boosted were healthier in the first place, inflating estimates of how protective the vaccines initially were. Sinovac, a private Chinese company that makes the vaccine, is one of two manufacturers of Covid shots available in China. Vaccines using mRNA technology, like those made by Pfizer-BioNTech and Moderna, are not available there. The new study highlights the potential consequences for China, which has relied heavily on Sinovac and is battling its biggest Covid outbreak in two years. More than 87 percent of China’s population has been vaccinated. But just over half of people 80 and older have had two shots, and less than 20 percent of people in that age group have received a booster, Zeng Yixin, a vice minister of the National Health Commission, said recently. ## Editors’ Picks [![](https://static01.nyt.com/images/2026/02/07/multimedia/07cul-songs-hwfk/07cul-songs-hwfk-thumbLarge.jpg)9 Songs We’re Talking About This Week](https://www.nytimes.com/2026/02/07/arts/music/ejae-sombr-new-songs.html) [![](https://static01.nyt.com/images/2026/02/07/multimedia/07re-wallpaper-mcjf/07re-wallpaper-mcjf-thumbLarge.jpg)How to Choose Wallpaper Like a Professional Designer](https://www.nytimes.com/2026/02/07/realestate/how-to-choose-wallpaper.html) [![](https://static01.nyt.com/images/2026/02/14/magazine/14mag-ethicist/14mag-ethicist-thumbLarge.jpg)My Cousin Is About to Become Homeless. How Much Should I Give Up for Him?](https://www.nytimes.com/2026/02/07/magazine/cousin-homeless-ethics.html) Advertisement [SKIP ADVERTISEMENT](https://www.nytimes.com/2022/03/23/health/sinovac-coronavirus-booster-hong-kong.html#after-pp_edpick) The new study from Hong Kong received funding from the Chinese Center for Disease Control and Prevention as part of what one of the study’s co-authors described this week as an effort to understand the comparative effectiveness of vaccines. It was posted online as a preprint, but has not yet been vetted by peer scientists for publication in a scientific journal. Sinovac’s vaccine performed similarly to Pfizer’s among younger people, even without a booster dose, the study found. In people younger than 60, two Sinovac doses were roughly 92 percent effective against severe or fatal Covid, whereas two Pfizer doses were about 95 percent effective. [![](https://static01.nyt.com/images/2020/09/18/us/coronavirus-vaccine-tracker-promo-1600439734668/coronavirus-vaccine-tracker-promo-1600439734668-articleLarge-v132.png)Coronavirus Vaccine Tracker A look at all the vaccines that have reached trials in humans.](https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html) Neither vaccine provided very much protection against mild or moderate Covid, though Pfizer’s offered more than Sinovac’s and a booster dose considerably lifted levels of protection. During the latest wave, people in Hong Kong have largely been infected by the subvariant of [Omicron known as BA.2.](https://www.nytimes.com/article/omicron-variant-ba2.html) Like other versions of Omicron, BA.2 has infected many vaccinated people. The Hong Kong wave is killing people at a rate exceeding that of almost any country since the coronavirus emerged — a result, in large part, of low vaccination rates among older residents. Almost 90 percent of people who died during the latest wave were not fully immunized, suggesting that getting shots to the most vulnerable is more important than the particular brand of vaccine. Like Hong Kong, mainland China had largely succeeded in tamping down transmission of the virus before Omicron, leaving its population with very little immunity from previous infections. Beyond China, Sinovac vaccines have also been critical in protecting people against severe Covid, especially in poorer countries. The vaccine is being used in 49 countries, including in South America and Africa. But concerns about the protection it offered had already prompted the World Health Organization to [recommend in October](https://news.un.org/en/story/2021/10/1102732) that recipients 60 and older get a third dose. Dr. Andrew Morris, an infectious disease specialist at Sinai Health and University Health Network in Toronto, who was not involved with the Hong Kong study, said that the results fit with [lab studies](https://www.nytimes.com/2021/12/15/world/asia/omicron-hong-kong-study.html) suggesting that Sinovac generated lower levels of neutralizing antibodies than mRNA vaccines, like Pfizer’s. “I think what we’ll see is in countries that have relied heavily on Sinovac, if they don’t have boosting — especially with an mRNA booster, or even with Sinovac — they’re probably going to struggle with high rates of infection with this latest BA.2 wave,” he said. Dr. Morris said that the results in Hong Kong, like those from other vaccine studies, were also highly dependent on how long it had been since people were administered the shots. Protection tends to weaken over time. The results from the latest study about the effectiveness of third Sinovac doses might be taken as an encouraging sign by Chinese leaders that Chinese-made vaccines could remain the focus of their immunization campaign, said Dr. Huang, of the Council on Foreign Relations. “Now, for the Chinese leaders, they don’t need to face a strong pressure to approve BioNTech’s vaccine,” he said. Chinese Vaccines and Omicron [![]()Omicron: What We Know About the Dominant Coronavirus Variant](https://www.nytimes.com/article/omicron-coronavirus-variant.html) [![]()High Death Rate in Hong Kong Shows Importance of Vaccinating the Elderly March 21, 2022](https://www.nytimes.com/2022/03/21/health/covid-hong-kong-deaths.html) [![]()Hong Kong researchers find that two doses of China’s Sinovac vaccine are inadequate against Omicron. Dec. 15, 2021](https://www.nytimes.com/2021/12/15/world/asia/omicron-hong-kong-study.html) [![]()These Vaccines Have Been Embraced by the World. Why Not in China? Feb. 18, 2022](https://www.nytimes.com/2022/02/18/business/china-coronavirus-vaccines.html) [Benjamin Mueller](https://www.nytimes.com/by/benjamin-mueller) is a health and science reporter. Previously, he covered the coronavirus pandemic as a correspondent in London and the police in New York. A version of this article appears in print on March 24, 2022, Section A, Page 6 of the New York edition with the headline: Study of Chinese Vaccine Finds Booster Significantly Adds to Protection. [Order Reprints](https://nytimes.wrightsmedia.com/) \| [Today’s Paper](https://www.nytimes.com/section/todayspaper) \| [Subscribe](https://www.nytimes.com/subscriptions/Multiproduct/lp8HYKU.html?campaignId=48JQY) See more on: [BioNTech SE](https://www.nytimes.com/topic/biontech-se), [Pfizer Inc.](https://www.nytimes.com/topic/company/pfizer-inc) - Share full article ## Related Content ### [The Covid-19 Pandemic](https://www.nytimes.com/news-event/coronavirus) - [Milan Athletes Welcome Return of Winter Olympics Spectators](https://www.nytimes.com/2026/02/06/world/europe/2026-olympics-opening-ceremony-crowd-athletes.html) ![Empty seats at the speedskating finals during the 2022 Winter Olympics in Beijing. ](https://static01.nyt.com/images/2026/02/06/multimedia/06oly-opening-live-spectators-are-back-gjht/06oly-opening-live-spectators-are-back-gjht-thumbLarge.jpg?quality=75&auto=webp&disable=upscale) Gabriela Bhaskar for The New York Times - [Federal Vaccine Advisers Take Aim at Covid Shots](https://www.nytimes.com/2026/02/06/health/vaccines-covid-acip-malone-kennedy.html) ![Dr. Robert Malone, during a December meeting of the Advisory Committee on Immunization Practices in Atlanta.](https://static01.nyt.com/images/2026/02/06/multimedia/06HS-acip-bchk/06HS-acip-bchk-thumbLarge.jpg?quality=75&auto=webp&disable=upscale) Alyssa Pointer/Reuters - [He Built a Server to Protect Indigenous Health Data](https://www.nytimes.com/2026/02/05/science/lost-science-yracheta-indigenous.html) Tara Weston for The New York Times ### [More in Health](https://www.nytimes.com/section/health) - [Research Finds Interaction With Father, Not Mother, Affects Child Health](https://www.nytimes.com/2026/02/03/health/fathers-child-health.html) ![The children of less attentive fathers in the study were more likely to have poor heart or metabolic health.](https://static01.nyt.com/images/2026/02/03/multimedia/23hs-fathers-coparenting-ptlw/23hs-fathers-coparenting-ptlw-square640.jpg?quality=75&auto=webp&disable=upscale) Alamy - [4 Dead in Mushroom Poisoning Outbreak in California](https://www.nytimes.com/2026/02/08/us/california-mushrooms-deaths.html) ![Complications from death cap mushroom poisoning can include liver and kidney failure and seizures.](https://static01.nyt.com/images/2026/02/08/multimedia/08xp-mushrooms1-mgkq/08xp-mushrooms1-mgkq-square640.jpg?quality=75&auto=webp&disable=upscale) California Department of Public Health, via Associated Press - [Woman Wins Malpractice Suit Over Gender Surgery as a Minor](https://www.nytimes.com/2026/02/03/health/gender-surgery-malpractice-varian.html) ![Recent studies have suggested that between 5 and 10 percent of young people who had undergone gender-affirming care later decided to detransition.](https://static01.nyt.com/images/2026/02/02/multimedia/02hs-gender-surgery-jlgp/02hs-gender-surgery-jlgp-square640.jpg?quality=75&auto=webp&disable=upscale) Evelyn Hockstein/Reuters - [Trump Administration to Cut \$600 Million in Health Funding From Four States](https://www.nytimes.com/2026/02/09/health/trump-public-health-cuts-california.html) ![Cuts totaling about \$600 million will affect funds to health departments and smaller partner organizations, including the Lurie Children’s Hospital of Chicago.](https://static01.nyt.com/images/2026/02/09/multimedia/09HS-cdc-jgcm/09HS-cdc-jgcm-square640.jpg?quality=75&auto=webp&disable=upscale) Scott Olson/Getty Images ### Editors’ Picks - [Move Over, Girl Dinner. Boy Kibble Has Arrived.](https://www.nytimes.com/2026/02/09/style/boy-kibble-ground-beef-protein-dinner.html) ![From left, Patrick Kong, Cameron Cardenas and Regin Mantuano showing off their ground beef bowls on social media.](https://static01.nyt.com/images/2026/03/02/fashion/02ST-GROUNDBEEF/02ST-GROUNDBEEF-square640.png?quality=75&auto=webp&disable=upscale) - [Halle Berry and Van Hunt’s Engagement Comes With a Nod to Vintage Elegance](https://www.nytimes.com/2026/02/06/style/halle-berry-van-hunt-engaged.html) ![Halle Berry shows off a vintage-inspired engagement ring on “The Tonight Show Starring Jimmy Fallon,” joining celebrities like Taylor Swift in embracing the timeless style.](https://static01.nyt.com/images/2026/02/06/multimedia/06ST-HALLE-BERRY-ENGAGEMENT-RING-03-pbmq/06ST-HALLE-BERRY-ENGAGEMENT-RING-03-pbmq-square640.jpg?quality=75&auto=webp&disable=upscale) NBC ### Trending in The Times - [Newly Unbound, Trump Weighs More Nuclear Arms and Underground Tests](https://www.nytimes.com/2026/02/09/us/politics/trump-nuclear-arms-underground-tests.html) ![An underground atomic test at the Nevada Test Site near Yucca Flats in 1955. The last U.S. explosive test of a nuclear weapon was in 1992.](https://static01.nyt.com/images/2026/02/09/multimedia/09dc-nukes-photo-wbht/09dc-nukes-photo-wbht-square640.jpg?quality=75&auto=webp&disable=upscale&width=350) U.S. Atomic Energy Commission, via Associated Press - [Stop Using Liquid Dishwasher Detergent](https://www.nytimes.com/video/smarter-living/wirecutter/100000010699991/stop-using-liquid-dishwasher-detergent.html) ![](https://static01.nyt.com/images/2026/02/09/smarter-living/wirecutter/THUMB_260123_WC_WILI_DISHDETERGENT_WL_V6/THUMB_260123_WC_WILI_DISHDETERGENT_WL_V6-square640.jpg?quality=75&auto=webp&disable=upscale&width=350) - [Bad Bunny’s Halftime Show: Our Instant Reactions](https://www.nytimes.com/2026/02/08/arts/music/bad-bunny-super-bowl-halftime-reactions.html) ![](https://static01.nyt.com/images/2026/02/08/podcasts/08popcast-bad-bunny-halftime-show/08popcast-bad-bunny-halftime-show-square640-v2.png?quality=75&auto=webp&disable=upscale&width=350) Photo Illustration by The New York Times; Photo: Loren Elliott for The New York Times - [Do You Need These Popular Supplements?](https://www.nytimes.com/2026/02/09/well/eat/supplement-swaps-nutrition-food.html) ![](https://static01.nyt.com/images/2026/02/09/multimedia/09WELL-SUPPLEMENTS-SWAPS14-tvpk/09WELL-SUPPLEMENTS-SWAPS14-tvpk-square640.jpg?quality=75&auto=webp&disable=upscale&width=350) Image by Ghazalle Badiozamani for The New York Times - [Opinion: Want More Babies? Abolish Commutes.](https://www.nytimes.com/2026/02/09/opinion/fertility-rate-baby-work-from-home.html) ![](https://static01.nyt.com/images/2026/02/09/arts/09lipman-still/09lipman-still-square640.png?quality=75&auto=webp&disable=upscale&width=350) Image by Alexandre Louvenaz - [Olympic P.S.A.: Do Not Jump for Joy While Wearing Your Medal](https://www.nytimes.com/2026/02/09/sports/olympics-medals-broken-breezy-johnson.html) ![Breezy Johnson of the United States posing with her gold medal for downhill skiing at the medal ceremony on Sunday.](https://static01.nyt.com/images/2026/02/09/multimedia/09xp-medals1-zcvg/09xp-medals1-zcvg-square640.jpg?quality=75&auto=webp&disable=upscale&width=350) Image by James Hill for The New York Times - [These Birds Are of Different Feathers, but They Flock Together](https://www.nytimes.com/2026/02/09/science/birds-preening-species-texas.html) ![An instance of interspecific allopreening, as ornithologists call it, between a crested caracara, right, and a black vulture in San Antonio.](https://static01.nyt.com/images/2026/02/09/multimedia/09HS-tb-bird-friends-01-jtcp/09HS-tb-bird-friends-01-jtcp-square640.jpg?quality=75&auto=webp&disable=upscale&width=350) Lora Reynolds - [A YouTuber’s Film Beat ‘Melania’ at the Box Office. Here’s How.](https://www.nytimes.com/2026/02/09/movies/markiplier-iron-lung-movie.html) ![Mark Fischbach, known as Markiplier, directed and funded “Iron Lung” himself.](https://static01.nyt.com/images/2026/02/10/multimedia/09cul-youtube-movie-2-vbcj/09cul-youtube-movie-2-vbcj-square640.jpg?quality=75&auto=webp&disable=upscale&width=350) Natasha Campos/Getty Images For Mark Markiplier - [Get Rid of Lingering Garlic Smells](https://www.nytimes.com/video/smarter-living/wirecutter/100000010699954/get-rid-of-lingering-garlic-smells.html) ![](https://static01.nyt.com/images/2026/02/09/smarter-living/wirecutter/THUMBNAIL_260202_WC_NYK_GARLIC_SMELLS_STEEL_SPOON_ES/THUMBNAIL_260202_WC_NYK_GARLIC_SMELLS_STEEL_SPOON_ES--square640.jpg?quality=75&auto=webp&disable=upscale&width=350) - [Record-Breaking 244-Pound Atlantic Halibut Caught in Quebec](https://www.nytimes.com/video/world/canada/100000010695717/record-atlantic-halibut-fishing-quebec.html) ![](https://static01.nyt.com/images/2026/02/06/world/canada/Halibut_Thumb_v5/Halibut_Thumb_v5-square640.jpg?quality=75&auto=webp&disable=upscale&width=350) Alain Hamel Advertisement [SKIP ADVERTISEMENT](https://www.nytimes.com/2022/03/23/health/sinovac-coronavirus-booster-hong-kong.html#after-bottom) ## Site Index [Go to Home Page »](https://www.nytimes.com/) News - [Home Page](https://www.nytimes.com/) - [U.S.](https://www.nytimes.com/section/us) - [World](https://www.nytimes.com/section/world) - [Politics](https://www.nytimes.com/section/politics) - [New York](https://www.nytimes.com/section/nyregion) - [Education](https://www.nytimes.com/section/education) - [Sports](https://www.nytimes.com/section/sports) - [Business](https://www.nytimes.com/section/business) - [Tech](https://www.nytimes.com/section/technology) - [Science](https://www.nytimes.com/section/science) - [Weather](https://www.nytimes.com/section/weather) - [The Great Read](https://www.nytimes.com/spotlight/the-great-read) - [Obituaries](https://www.nytimes.com/section/obituaries) - [Headway](https://www.nytimes.com/section/headway) - [Visual Investigations](https://www.nytimes.com/spotlight/visual-investigations) - [The Magazine](https://www.nytimes.com/section/magazine) Arts - [Book Review](https://www.nytimes.com/section/books/review) - [Best Sellers Book List](https://www.nytimes.com/books/best-sellers/) - [Dance](https://www.nytimes.com/section/arts/dance) - [Movies](https://www.nytimes.com/section/movies) - [Music](https://www.nytimes.com/section/arts/music) - [Pop Culture](https://www.nytimes.com/spotlight/pop-culture) - [Television](https://www.nytimes.com/section/arts/television) - [Theater](https://www.nytimes.com/section/theater) - [Visual Arts](https://www.nytimes.com/section/arts/design) Lifestyle - [Health](https://www.nytimes.com/section/health) - [Well](https://www.nytimes.com/section/well) - [Food](https://www.nytimes.com/section/food) - [Restaurant Reviews](https://www.nytimes.com/reviews/dining) - [Love](https://www.nytimes.com/section/fashion/weddings) - [Travel](https://www.nytimes.com/section/travel) - [Style](https://www.nytimes.com/section/style) - [Fashion](https://www.nytimes.com/section/fashion) - [Real Estate](https://www.nytimes.com/section/realestate) - [T Magazine](https://www.nytimes.com/section/t-magazine) Opinion - [Today's Opinion](https://www.nytimes.com/section/opinion) - [Columnists](https://www.nytimes.com/section/opinion/columnists) - [Editorials](https://www.nytimes.com/section/opinion/editorials) - [Guest Essays](https://www.nytimes.com/section/opinion/contributors) - [Op-Docs](https://www.nytimes.com/column/op-docs) - [Letters](https://www.nytimes.com/section/opinion/letters) - [Sunday Opinion](https://www.nytimes.com/section/opinion/sunday) - [Opinion Video](https://www.nytimes.com/spotlight/opinion-video) - [Opinion Audio](https://www.nytimes.com/series/opinion-audio) More - [Audio](https://www.nytimes.com/spotlight/podcasts) - [Games](https://www.nytimes.com/crosswords) - [Cooking](https://cooking.nytimes.com/) - [Wirecutter](https://www.nytimes.com/wirecutter/) - [The Athletic](https://www.nytimes.com/athletic/) - [Jobs](https://www.nytimes.com/section/jobs) - [Video](https://www.nytimes.com/video) - [Graphics](https://www.nytimes.com/spotlight/graphics) - [Trending](https://www.nytimes.com/trending/) - [Live Events](https://www.nytimes.com/spotlight/nyt-events) - [Corrections](https://www.nytimes.com/section/corrections) - [Reader Center](https://www.nytimes.com/section/reader-center) - [TimesMachine](https://timesmachine.nytimes.com/browser) - [The Learning Network](https://www.nytimes.com/section/learning) - [School of The NYT](https://nytedu.com/) - [inEducation](https://www.nytimes.com/spotlight/nytimesineducation) ### News - [Home Page](https://www.nytimes.com/) - [U.S.](https://www.nytimes.com/section/us) - [World](https://www.nytimes.com/section/world) - [Politics](https://www.nytimes.com/section/politics) - [New York](https://www.nytimes.com/section/nyregion) - [Education](https://www.nytimes.com/section/education) - [Sports](https://www.nytimes.com/section/sports) - [Business](https://www.nytimes.com/section/business) - [Tech](https://www.nytimes.com/section/technology) - [Science](https://www.nytimes.com/section/science) - [Weather](https://www.nytimes.com/section/weather) - [The Great Read](https://www.nytimes.com/spotlight/the-great-read) - [Obituaries](https://www.nytimes.com/section/obituaries) - [Headway](https://www.nytimes.com/section/headway) - [Visual Investigations](https://www.nytimes.com/spotlight/visual-investigations) - [The Magazine](https://www.nytimes.com/section/magazine) ### Arts - [Book Review](https://www.nytimes.com/section/books/review) - [Best Sellers Book List](https://www.nytimes.com/books/best-sellers/) - [Dance](https://www.nytimes.com/section/arts/dance) - [Movies](https://www.nytimes.com/section/movies) - [Music](https://www.nytimes.com/section/arts/music) - [Pop Culture](https://www.nytimes.com/spotlight/pop-culture) - [Television](https://www.nytimes.com/section/arts/television) - [Theater](https://www.nytimes.com/section/theater) - [Visual Arts](https://www.nytimes.com/section/arts/design) ### Lifestyle - [Health](https://www.nytimes.com/section/health) - [Well](https://www.nytimes.com/section/well) - [Food](https://www.nytimes.com/section/food) - [Restaurant Reviews](https://www.nytimes.com/reviews/dining) - [Love](https://www.nytimes.com/section/fashion/weddings) - [Travel](https://www.nytimes.com/section/travel) - [Style](https://www.nytimes.com/section/style) - [Fashion](https://www.nytimes.com/section/fashion) - [Real Estate](https://www.nytimes.com/section/realestate) - [T Magazine](https://www.nytimes.com/section/t-magazine) ### Opinion - [Today's Opinion](https://www.nytimes.com/section/opinion) - [Columnists](https://www.nytimes.com/section/opinion/columnists) - [Editorials](https://www.nytimes.com/section/opinion/editorials) - [Guest Essays](https://www.nytimes.com/section/opinion/contributors) - [Op-Docs](https://www.nytimes.com/column/op-docs) - [Letters](https://www.nytimes.com/section/opinion/letters) - [Sunday Opinion](https://www.nytimes.com/section/opinion/sunday) - [Opinion Video](https://www.nytimes.com/spotlight/opinion-video) - [Opinion Audio](https://www.nytimes.com/series/opinion-audio) ### More - [Audio](https://www.nytimes.com/spotlight/podcasts) - [Games](https://www.nytimes.com/crosswords) - [Cooking](https://cooking.nytimes.com/) - [Wirecutter](https://www.nytimes.com/wirecutter/) - [The Athletic](https://www.nytimes.com/athletic/) - [Jobs](https://www.nytimes.com/section/jobs) - [Video](https://www.nytimes.com/video) - [Graphics](https://www.nytimes.com/spotlight/graphics) - [Trending](https://www.nytimes.com/trending/) - [Live Events](https://www.nytimes.com/spotlight/nyt-events) - [Corrections](https://www.nytimes.com/section/corrections) - [Reader Center](https://www.nytimes.com/section/reader-center) - [TimesMachine](https://timesmachine.nytimes.com/browser) - [The Learning Network](https://www.nytimes.com/section/learning) - [School of The NYT](https://nytedu.com/) - [inEducation](https://www.nytimes.com/spotlight/nytimesineducation) ### Account - [Subscribe](https://www.nytimes.com/subscription) - [Manage My Account](https://www.nytimes.com/account) - [Home Delivery](https://www.nytimes.com/subscription/home-delivery) - [Gift Subscriptions](https://www.nytimes.com/gift) - [Group Subscriptions](https://www.nytimes.com/subscription/groups?Pardot_Campaign_Code_Form_Input=89FQX) - [Gift Articles](https://www.nytimes.com/gift-articles) - [Email Newsletters](https://www.nytimes.com/newsletters) - [NYT Licensing](https://nytlicensing.com/) - [Replica Edition](https://nytimes.pressreader.com/) - [Times Store](https://store.nytimes.com/) ## Site Information Navigation - [© 2026 The New York Times Company](https://help.nytimes.com/hc/en-us/articles/115014792127-Copyright-Notice) - [NYTCo](https://www.nytco.com/) - [Contact Us](https://help.nytimes.com/hc/en-us/articles/115015385887-Contact-The-New-York-Times) - [Accessibility](https://help.nytimes.com/hc/en-us/articles/115015727108-Accessibility) - [Work with us](https://www.nytco.com/careers/) - [Advertise](https://advertising.nytimes.com/) - [T Brand Studio](https://advertising.nytimes.com/custom-content/) - [Privacy Policy](https://help.nytimes.com/hc/en-us/articles/10940941449492-The-New-York-Times-Company-Privacy-Policy) - [Cookie Policy](https://www.nytimes.com/privacy/cookie-policy) - [Terms of Service](https://help.nytimes.com/hc/en-us/articles/115014893428-Terms-of-Service) - [Terms of Sale](https://help.nytimes.com/hc/en-us/articles/115014893968-Terms-of-Sale) - [Site Map](https://www.nytimes.com/sitemap/) - [Canada](https://www.nytimes.com/ca/) - [International](https://www.nytimes.com/international/) - [Help](https://help.nytimes.com/hc/en-us) - [Subscriptions](https://www.nytimes.com/subscription?campaignId=37WXW)
Readable Markdown
Advertisement [SKIP ADVERTISEMENT](https://www.nytimes.com/2022/03/23/health/sinovac-coronavirus-booster-hong-kong.html#after-top) Given the surge of Omicron cases in Asia, the new research lends urgency to vaccination campaigns in China and Hong Kong. ![](https://static01.nyt.com/images/2022/03/23/science/23VIRUS-SINOVAC/merlin_203634372_62932c1b-ed9b-4ba6-8f77-b7db8021bbd8-articleLarge.jpg?quality=75&auto=webp&disable=upscale) Masks were distributed to people leaving a Sinovac vaccination site in Hong Kong this month.Credit...Dale De La Rey/Agence France-Presse — Getty Images March 23, 2022 Two doses of China’s Sinovac vaccine offered older people only a moderately high level of protection against severe disease and death from Covid-19, but a third dose significantly bolstered their defenses, according to a [new study by scientists in Hong Kong](https://www.medrxiv.org/content/10.1101/2022.03.22.22272769v1). The study, based on patients infected during the current devastating [Omicron wave in Hong Kong](https://www.nytimes.com/2022/03/21/health/covid-hong-kong-deaths.html), serves as a cautionary note for mainland China, where Sinovac is a pillar of the country’s vaccination program. Many older people there have yet to receive booster shots. For people 60 and older, two Sinovac doses were 72 percent effective against severe or fatal Covid-19 and 77 percent effective against Covid-related death, the study found. Those levels of protection were lower than those provided by two Pfizer-BioNTech doses. The same study found they were 90 percent effective against severe or fatal Covid and 92 percent effective against death among Hong Kong residents of the same age group. A Sinovac booster shot helped considerably, proving to be 98 percent effective against severe or fatal Covid among people at least 60 years old, the study found. Yanzhong Huang, a global health expert at the Council on Foreign Relations, said that the results highlighted the urgency for mainland China to accelerate its lagging booster campaign. “There’s a lot of work for the government to do to make sure this segment of the population receives the booster shots,” he said. The study’s authors, who are scientists at the University of Hong Kong, noted that the city’s booster program began just recently, making it difficult to determine how long protection from a third dose would last. Because people with underlying health conditions in Hong Kong were more likely to resist getting vaccinated, they said, it was also possible that those who chose to be vaccinated or boosted were healthier in the first place, inflating estimates of how protective the vaccines initially were. Sinovac, a private Chinese company that makes the vaccine, is one of two manufacturers of Covid shots available in China. Vaccines using mRNA technology, like those made by Pfizer-BioNTech and Moderna, are not available there. The new study highlights the potential consequences for China, which has relied heavily on Sinovac and is battling its biggest Covid outbreak in two years. More than 87 percent of China’s population has been vaccinated. But just over half of people 80 and older have had two shots, and less than 20 percent of people in that age group have received a booster, Zeng Yixin, a vice minister of the National Health Commission, said recently. The new study from Hong Kong received funding from the Chinese Center for Disease Control and Prevention as part of what one of the study’s co-authors described this week as an effort to understand the comparative effectiveness of vaccines. It was posted online as a preprint, but has not yet been vetted by peer scientists for publication in a scientific journal. Sinovac’s vaccine performed similarly to Pfizer’s among younger people, even without a booster dose, the study found. In people younger than 60, two Sinovac doses were roughly 92 percent effective against severe or fatal Covid, whereas two Pfizer doses were about 95 percent effective. Neither vaccine provided very much protection against mild or moderate Covid, though Pfizer’s offered more than Sinovac’s and a booster dose considerably lifted levels of protection. During the latest wave, people in Hong Kong have largely been infected by the subvariant of [Omicron known as BA.2.](https://www.nytimes.com/article/omicron-variant-ba2.html) Like other versions of Omicron, BA.2 has infected many vaccinated people. The Hong Kong wave is killing people at a rate exceeding that of almost any country since the coronavirus emerged — a result, in large part, of low vaccination rates among older residents. Almost 90 percent of people who died during the latest wave were not fully immunized, suggesting that getting shots to the most vulnerable is more important than the particular brand of vaccine. Like Hong Kong, mainland China had largely succeeded in tamping down transmission of the virus before Omicron, leaving its population with very little immunity from previous infections. Beyond China, Sinovac vaccines have also been critical in protecting people against severe Covid, especially in poorer countries. The vaccine is being used in 49 countries, including in South America and Africa. But concerns about the protection it offered had already prompted the World Health Organization to [recommend in October](https://news.un.org/en/story/2021/10/1102732) that recipients 60 and older get a third dose. Dr. Andrew Morris, an infectious disease specialist at Sinai Health and University Health Network in Toronto, who was not involved with the Hong Kong study, said that the results fit with [lab studies](https://www.nytimes.com/2021/12/15/world/asia/omicron-hong-kong-study.html) suggesting that Sinovac generated lower levels of neutralizing antibodies than mRNA vaccines, like Pfizer’s. “I think what we’ll see is in countries that have relied heavily on Sinovac, if they don’t have boosting — especially with an mRNA booster, or even with Sinovac — they’re probably going to struggle with high rates of infection with this latest BA.2 wave,” he said. Dr. Morris said that the results in Hong Kong, like those from other vaccine studies, were also highly dependent on how long it had been since people were administered the shots. Protection tends to weaken over time. The results from the latest study about the effectiveness of third Sinovac doses might be taken as an encouraging sign by Chinese leaders that Chinese-made vaccines could remain the focus of their immunization campaign, said Dr. Huang, of the Council on Foreign Relations. “Now, for the Chinese leaders, they don’t need to face a strong pressure to approve BioNTech’s vaccine,” he said. [Benjamin Mueller](https://www.nytimes.com/by/benjamin-mueller) is a health and science reporter. Previously, he covered the coronavirus pandemic as a correspondent in London and the police in New York. A version of this article appears in print on March 24, 2022, Section A, Page 6 of the New York edition with the headline: Study of Chinese Vaccine Finds Booster Significantly Adds to Protection. [Order Reprints](https://nytimes.wrightsmedia.com/) \| [Today’s Paper](https://www.nytimes.com/section/todayspaper) \| [Subscribe](https://www.nytimes.com/subscriptions/Multiproduct/lp8HYKU.html?campaignId=48JQY) ## Related Content [The Covid-19 Pandemic](https://www.nytimes.com/news-event/coronavirus) - ![Empty seats at the speedskating finals during the 2022 Winter Olympics in Beijing. ](https://static01.nyt.com/images/2026/02/06/multimedia/06oly-opening-live-spectators-are-back-gjht/06oly-opening-live-spectators-are-back-gjht-thumbLarge.jpg?quality=75&auto=webp&disable=upscale) Gabriela Bhaskar for The New York Times - ![Dr. Robert Malone, during a December meeting of the Advisory Committee on Immunization Practices in Atlanta.](https://static01.nyt.com/images/2026/02/06/multimedia/06HS-acip-bchk/06HS-acip-bchk-thumbLarge.jpg?quality=75&auto=webp&disable=upscale) Alyssa Pointer/Reuters - Tara Weston for The New York Times [More in Health](https://www.nytimes.com/section/health) - ![The children of less attentive fathers in the study were more likely to have poor heart or metabolic health.](https://static01.nyt.com/images/2026/02/03/multimedia/23hs-fathers-coparenting-ptlw/23hs-fathers-coparenting-ptlw-square640.jpg?quality=75&auto=webp&disable=upscale) Alamy - ![Complications from death cap mushroom poisoning can include liver and kidney failure and seizures.](https://static01.nyt.com/images/2026/02/08/multimedia/08xp-mushrooms1-mgkq/08xp-mushrooms1-mgkq-square640.jpg?quality=75&auto=webp&disable=upscale) California Department of Public Health, via Associated Press - ![Recent studies have suggested that between 5 and 10 percent of young people who had undergone gender-affirming care later decided to detransition.](https://static01.nyt.com/images/2026/02/02/multimedia/02hs-gender-surgery-jlgp/02hs-gender-surgery-jlgp-square640.jpg?quality=75&auto=webp&disable=upscale) Evelyn Hockstein/Reuters - ![Cuts totaling about \$600 million will affect funds to health departments and smaller partner organizations, including the Lurie Children’s Hospital of Chicago.](https://static01.nyt.com/images/2026/02/09/multimedia/09HS-cdc-jgcm/09HS-cdc-jgcm-square640.jpg?quality=75&auto=webp&disable=upscale) Scott Olson/Getty Images Editors’ Picks - ![From left, Patrick Kong, Cameron Cardenas and Regin Mantuano showing off their ground beef bowls on social media.](https://static01.nyt.com/images/2026/03/02/fashion/02ST-GROUNDBEEF/02ST-GROUNDBEEF-square640.png?quality=75&auto=webp&disable=upscale) - ![Halle Berry shows off a vintage-inspired engagement ring on “The Tonight Show Starring Jimmy Fallon,” joining celebrities like Taylor Swift in embracing the timeless style.](https://static01.nyt.com/images/2026/02/06/multimedia/06ST-HALLE-BERRY-ENGAGEMENT-RING-03-pbmq/06ST-HALLE-BERRY-ENGAGEMENT-RING-03-pbmq-square640.jpg?quality=75&auto=webp&disable=upscale) NBC Trending in The Times - ![An underground atomic test at the Nevada Test Site near Yucca Flats in 1955. The last U.S. explosive test of a nuclear weapon was in 1992.](https://static01.nyt.com/images/2026/02/09/multimedia/09dc-nukes-photo-wbht/09dc-nukes-photo-wbht-square640.jpg?quality=75&auto=webp&disable=upscale&width=350) U.S. Atomic Energy Commission, via Associated Press - ![](https://static01.nyt.com/images/2026/02/09/smarter-living/wirecutter/THUMB_260123_WC_WILI_DISHDETERGENT_WL_V6/THUMB_260123_WC_WILI_DISHDETERGENT_WL_V6-square640.jpg?quality=75&auto=webp&disable=upscale&width=350) - ![](https://static01.nyt.com/images/2026/02/08/podcasts/08popcast-bad-bunny-halftime-show/08popcast-bad-bunny-halftime-show-square640-v2.png?quality=75&auto=webp&disable=upscale&width=350) Photo Illustration by The New York Times; Photo: Loren Elliott for The New York Times - ![](https://static01.nyt.com/images/2026/02/09/multimedia/09WELL-SUPPLEMENTS-SWAPS14-tvpk/09WELL-SUPPLEMENTS-SWAPS14-tvpk-square640.jpg?quality=75&auto=webp&disable=upscale&width=350) Image by Ghazalle Badiozamani for The New York Times - ![](https://static01.nyt.com/images/2026/02/09/arts/09lipman-still/09lipman-still-square640.png?quality=75&auto=webp&disable=upscale&width=350) Image by Alexandre Louvenaz - ![Breezy Johnson of the United States posing with her gold medal for downhill skiing at the medal ceremony on Sunday.](https://static01.nyt.com/images/2026/02/09/multimedia/09xp-medals1-zcvg/09xp-medals1-zcvg-square640.jpg?quality=75&auto=webp&disable=upscale&width=350) Image by James Hill for The New York Times - ![An instance of interspecific allopreening, as ornithologists call it, between a crested caracara, right, and a black vulture in San Antonio.](https://static01.nyt.com/images/2026/02/09/multimedia/09HS-tb-bird-friends-01-jtcp/09HS-tb-bird-friends-01-jtcp-square640.jpg?quality=75&auto=webp&disable=upscale&width=350) Lora Reynolds - ![Mark Fischbach, known as Markiplier, directed and funded “Iron Lung” himself.](https://static01.nyt.com/images/2026/02/10/multimedia/09cul-youtube-movie-2-vbcj/09cul-youtube-movie-2-vbcj-square640.jpg?quality=75&auto=webp&disable=upscale&width=350) Natasha Campos/Getty Images For Mark Markiplier - ![](https://static01.nyt.com/images/2026/02/09/smarter-living/wirecutter/THUMBNAIL_260202_WC_NYK_GARLIC_SMELLS_STEEL_SPOON_ES/THUMBNAIL_260202_WC_NYK_GARLIC_SMELLS_STEEL_SPOON_ES--square640.jpg?quality=75&auto=webp&disable=upscale&width=350) - ![](https://static01.nyt.com/images/2026/02/06/world/canada/Halibut_Thumb_v5/Halibut_Thumb_v5-square640.jpg?quality=75&auto=webp&disable=upscale&width=350) Alain Hamel Advertisement [SKIP ADVERTISEMENT](https://www.nytimes.com/2022/03/23/health/sinovac-coronavirus-booster-hong-kong.html#after-bottom)
Shard84 (laksa)
Root Hash4566504020376537684
Unparsed URLcom,nytimes!www,/2022/03/23/health/sinovac-coronavirus-booster-hong-kong.html s443